FindTrial
Sign In

Comparing two drugs for surgical pain relief in breast surgeries

COMPARISON BETWEEN BUPIVACAINE AND ROPIVACAINE IN THORACIC EPIDURAL ANAESTHESIA FOR MODIFIED RADICAL MASTECTOMY â?? A RANDOMISED CONTROLLED TRIALâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018002
Enrollment
60
Registered
2019-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: THORACIC EPIDURAL ROPIVACAINE 0.5%: LOCAL ANAESTHETIC GIVEN VIA EPIDURAL CATHETER Control Intervention1: THORACIC EPIDURAL BUPIVACAINE 0.5%: LOCAL ANAESTHETIC GIVEN VIA EPIDURAL CATHETE

Sponsors

ESIC MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 to 70 years 2. ASA physical status I and II 3. Patients with informed written consent

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Patients with known history of allergy to local anaesthetics 3. Patients with local site infection 4. Patients with coagulopathy or bleeding disorders 5. Patients with severe spinal deformity

Design outcomes

Primary

MeasureTime frame
To compare the intra operative hemodynamics between 0.5 % bupivacaine and 0.5%ropivacine when when used in thoracic epidural for modified radical mastectomy.Timepoint: Intraoperatively every 15 minutes—

Secondary

MeasureTime frame
To compare the analgesia provided by 0.5 % bupivacaine and 0.5% ropivacine when used as a continuous epidural infusion in the post operative period for modified radical mastectomy. Timepoint: Post operatively every 4 hours—

Countries

India

Contacts

Public ContactDR ASWINI L

ESIC MEDICAL COLLEGE AND PGIMSR

aswinijipmer@gmail.com9442011352

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026